Correlation Between Akanda Corp and Sonoma Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akanda Corp and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akanda Corp and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akanda Corp and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Akanda Corp and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akanda Corp with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akanda Corp and Sonoma Pharmaceuticals.

Diversification Opportunities for Akanda Corp and Sonoma Pharmaceuticals

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Akanda and Sonoma is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Akanda Corp and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Akanda Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akanda Corp are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Akanda Corp i.e., Akanda Corp and Sonoma Pharmaceuticals go up and down completely randomly.

Pair Corralation between Akanda Corp and Sonoma Pharmaceuticals

Given the investment horizon of 90 days Akanda Corp is expected to under-perform the Sonoma Pharmaceuticals. In addition to that, Akanda Corp is 1.13 times more volatile than Sonoma Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Sonoma Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest  2,280  in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (1,987) from holding Sonoma Pharmaceuticals or give up 87.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Akanda Corp  vs.  Sonoma Pharmaceuticals

 Performance 
       Timeline  
Akanda Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akanda Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sonoma Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sonoma Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Akanda Corp and Sonoma Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akanda Corp and Sonoma Pharmaceuticals

The main advantage of trading using opposite Akanda Corp and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akanda Corp position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.
The idea behind Akanda Corp and Sonoma Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk